ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,701Medicare Part D Prescriptions Filled, Including Refills

Rank: 439 out of 2343

$700K Total Retail Price of All Prescriptions

Rank: 327 out of 2343

375 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 375 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 375 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,926 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 437 341 1 2
SIMVASTATIN 406 295 2 1
FUROSEMIDE 351 262 3 6
OMEPRAZOLE 254 152 4 4
BACLOFEN 230 44 5 161
TRAMADOL HCL 218 171 6 25
GABAPENTIN 210 148 7 16
METOPROLOL TARTRATE 196 147 8 7
LISINOPRIL 188 121 9 3
AMLODIPINE BESYLATE 187 167 10 5
LOSARTAN POTASSIUM 178 175 11 19
CITALOPRAM HBR 130 55 12 17
ALLOPURINOL 127 126 13 31
WARFARIN SODIUM 124 124 14 8
ZOLPIDEM TARTRATE 120 88 15 24
METFORMIN HCL 116 82 16 9
METOPROLOL SUCCINATE 109 91 17 14
IPRATROPIUM-ALBUTEROL 101 28 18 99
GLIMEPIRIDE 98 72 19 45
FENTANYL 98 47 S2 19 69
LACTULOSE 96 33 21 139
DONEPEZIL HCL 96 39 21 21
ATORVASTATIN CALCIUM 94 81 23 10
HYDROCHLOROTHIAZIDE 89 81 24 11
ATENOLOL 85 65 25 12
METOCLOPRAMIDE HCL 84 0 26 168
ESCITALOPRAM OXALATE 84 30 26 55
HYDROCODONE-ACETAMINOPHEN 83 49 S3 28 13
NEXIUM 83 54 28 33
QUETIAPINE FUMARATE 83 17 28 77
ALENDRONATE SODIUM 82 68 31 28
AMLODIPINE BESYLATE-BENAZEPRIL 79 56 32 59
ADVAIR DISKUS 79 62 32 34
CRESTOR 75 44 34 30
POTASSIUM CHLORIDE 74 44 35 18
TAMSULOSIN HCL 73 49 36 29
PREDNISONE 72 43 37 37
JANTOVEN 71 58 38 81
CLOPIDOGREL 67 57 39 26
PANTOPRAZOLE SODIUM 66 62 40 22
RANITIDINE HCL 65 20 41 43
FAMOTIDINE 64 29 42 60
JANUVIA 64 59 42 50
FLUTICASONE PROPIONATE 63 35 44 46
PRAVASTATIN SODIUM 62 51 45 15
TORSEMIDE 58 57 46 157
MIRTAZAPINE 58 31 46 41
CYMBALTA 57 28 48 74
CIPROFLOXACIN HCL 57 30 48 72
POLYETHYLENE GLYCOL 3350 56 13 50 54
ALBUTEROL SULFATE 54 35 51 126
NYSTATIN-TRIAMCINOLONE 54 11 51 249
PLAVIX 53 45 53 38
JANUMET 53 40 53 191
TRAZODONE HCL 52 23 55 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.